Current status of urine organic acid testing: heterogeneous practices and targets for harmonization

Background Organic acidurias are a heterogeneous group of inborn errors of metabolism (IEM) characterized by the accumulation of metabolites due to enzyme or transporter defects. Urine organic acid (UOA) analysis is a key biochemical genetics test for many IEMs. However, UOA procedures remain poorly harmonized, and proficiency testing data reveal substantial interlaboratory variation in performance. We evaluated current UOA practices to identify barriers to quality improvement and highlighted opportunities for harmonization. Method A structured questionnaire was used to capture key UOA workflows such as instrumentation, specimen rejection criteria, and quality assurance practices. Results Participating laboratories ( n = 32) reported moderate-to-high annual volumes (501–1000 tests in 38.7% and > 1000 in 32.3%), with analytical runtimes of 31–60 min per specimen. Creatinine normalization was the primary strategy for urine concentration adjustment, and visible contamination was the common reason for specimen rejection (43.1%). Quantitative practices varied: 63.4% quantified a subset or all analytes, whereas 36.7% relied on qualitative review. Interpretation was specialist-driven, with biochemical geneticists, clinical chemists, and pathologists accounting for 86.7%. Clinical information was inconsistently available for interpretation, and approaches to obtaining missing information varied. Difficult-to-analyze UOA included 3-hydroxyglutaric acid, mevalonolactone, and succinylacetone. Co-elution was the most common challenge, followed by recovery problems. Conclusions Biochemical genetics laboratories use a common core approach to UOA testing, based on GC–MS and trimethylsilyl derivatization. However, variability remains in specimen acceptance, pretreatment, oximation, quantitation, quality control, and interpretation. Our findings identify targets for harmonization, including biochemical genetics expert guidelines for preanalytical, analytical, and postanalytical steps.

Authors

Institutions

Publication Details

Journal
Molecular Genetics and Metabolism Reports
Published
2026-11-13
DOI
https://doi.org/10.1016/j.ymgmr.2026.101384
Primary Topic
Metabolism and Genetic Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Current status of urine organic acid testing: heterogeneous practices and targets for harmonization

Nathalie Lepage, Bright Amankwaa, Anna Scott
1 links
Molecular Genetics and Metabolism Reports
Metabolism and Genetic Disorders
article

Current status of urine organic acid testing: heterogeneous practices and targets for harmonization

Nathalie Lepage, Bright Amankwaa, Anna Scott
article en

Abstract

Background Organic acidurias are a heterogeneous group of inborn errors of metabolism (IEM) characterized by the accumulation of metabolites due to enzyme or transporter defects. Urine organic acid (UOA) analysis is a key biochemical genetics test for many IEMs. However, UOA procedures remain poorly harmonized, and proficiency testing data reveal substantial interlaboratory variation in performance. We evaluated current UOA practices to identify barriers to quality improvement and highlighted opportunities for harmonization. Method A structured questionnaire was used to capture key UOA workflows such as instrumentation, specimen rejection criteria, and quality assurance practices. Results Participating laboratories ( n = 32) reported moderate-to-high annual volumes (501–1000 tests in 38.7% and > 1000 in 32.3%), with analytical runtimes of 31–60 min per specimen. Creatinine normalization was the primary strategy for urine concentration adjustment, and visible contamination was the common reason for specimen rejection (43.1%). Quantitative practices varied: 63.4% quantified a subset or all analytes, whereas 36.7% relied on qualitative review. Interpretation was specialist-driven, with biochemical geneticists, clinical chemists, and pathologists accounting for 86.7%. Clinical information was inconsistently available for interpretation, and approaches to obtaining missing information varied. Difficult-to-analyze UOA included 3-hydroxyglutaric acid, mevalonolactone, and succinylacetone. Co-elution was the most common challenge, followed by recovery problems. Conclusions Biochemical genetics laboratories use a common core approach to UOA testing, based on GC–MS and trimethylsilyl derivatization. However, variability remains in specimen acceptance, pretreatment, oximation, quantitation, quality control, and interpretation. Our findings identify targets for harmonization, including biochemical genetics expert guidelines for preanalytical, analytical, and postanalytical steps.

Molecular Genetics and Metabolism ReportsVol. 49
Seattle Children's Hospital (US), University of Wisconsin–Madison (US), University of Washington (US), Children's Hospital of Eastern Ontario (CA)
Metabolism and Genetic Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon